Contractor profile
A&G PHARMACEUTICAL, INC.
Doing business as A & G PHARMACEUTICAL INC
Active registrationSmall Business
UEISN6SWFABJXL1
CAGE code1T9L5
Primary NAICS541714
LocationCOLUMBIA, MD, 21045
Federal obligations$148,751
Prime awards6
Active awards1
Latest award actionJul 20, 2026
Federal award activity
Public award recordTop federal customers
- Department of Health and Human Services6 awards$148,751
NAICS award mix
- 5417151 awards$83,401
- 5417141 awards$19,350
- 3254141 awards$16,900
- 5413801 awards$15,500
- 3259981 awards$13,600
- 3254121 awards$0
PSC award mix
- AN111 awards$83,401
- Q3012 awards$29,100
- 66401 awards$19,350
- 65052 awards$16,900
Contract vehicles
- 75N95018D000101 awards$83,401
Potential recompetes
- Department of Health and Human Services$13,600
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 75N98024A00057O/M ITEMS ONLY: BIOLOGICAL MATERIALS, LABORATORY & TESTING SERVICES, ANIMAL TESTING SERVICES | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | NAICS 325412PSC 6505 | $0 | Jan 30, 2024 – Not stated |
| 75N95022F00001POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | NAICS 541715PSC AN11 | $83,401 | Jun 30, 2022 – Mar 31, 2025 |
| 75N93024P01059PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | NAICS 541380PSC Q301 | $15,500 | Aug 27, 2024 – Nov 30, 2024 |
| 75N95C25P00114TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT. | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NCATS | NAICS 325998PSC Q301 | $13,600 | Sep 24, 2025 – Sep 23, 2026 |
| 75N93025P00729MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND MAB-P3-HC-001 (AMBIS #2254762) | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | NAICS 325414PSC 6505 | $16,900 | Mar 25, 2025 – Jul 31, 2025 |
| 75N91020P00499NIH-APPROVED COVID-RELATED PROJECT: ANALYSIS OF A NOVEL TRUNCATED FORM OF ACE2 RECEPTOR | Department of Health and Human ServicesNIH NCI | NAICS 541714PSC 6640 | $19,350 | Jun 18, 2020 – Jun 19, 2020 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
GINETTE SERREROCEOGovernment business
STEPHANIE MURCEKOFFICE MANAGERAlternate government business
GINETTE SERREROElectronic business
STEPHANIE MURCEKOFFICE MANAGERAlternate electronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.